Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SYMptom monitoring with Patient-Reported Outcomes using a web application among patients with Lung cancer in the Netherlands (SYMPRO-Lung): study protocol for a stepped-wedge randomised controlled trial.
Billingy NE, Tromp VNMF, Veldhuijzen E, Belderbos J, Aaronson NK, Feldman E, Hoek R, Bogaard HJ, Onwuteaka-Philipsen BD, van de Poll-Franse L, Hugtenburg JG, van den Hurk CJG, Becker-Commissaris A, Walraven I. Billingy NE, et al. Among authors: van den hurk cjg. BMJ Open. 2021 Sep 13;11(9):e052494. doi: 10.1136/bmjopen-2021-052494. BMJ Open. 2021. PMID: 34518276 Free PMC article.
A Narrative Review on the Collection and Use of Electronic Patient-Reported Outcomes in Cancer Survivorship Care with Emphasis on Symptom Monitoring.
van den Hurk CJG, Mols F, Eicher M, Chan RJ, Becker A, Geleijnse G, Walraven I, Coolbrandt A, Lustberg M, Velikova G, Charalambous A, Koczwara B, Howell D, Basch EM, van de Poll-Franse LV. van den Hurk CJG, et al. Curr Oncol. 2022 Jun 17;29(6):4370-4385. doi: 10.3390/curroncol29060349. Curr Oncol. 2022. PMID: 35735458 Free PMC article. Review.
Development of an updated, standardized, patient-centered outcome set for lung cancer.
de Rooij BH, van den Hurk C, Smaardijk V, Fernandez-Ortega P, Navarro-Martin A, Barberio L, Guckenberger M, Schmid S, Walraven I, Vallow S, Kotsi C, Preusser M, Mosor E, Klok JM, Becker A, Milani A, Ninov L, van de Poll-Franse LV. de Rooij BH, et al. Lung Cancer. 2022 Nov;173:5-13. doi: 10.1016/j.lungcan.2022.08.021. Epub 2022 Sep 5. Lung Cancer. 2022. PMID: 36103777 Free article.
Quality of life after patient-initiated vs physician-initiated response to symptom monitoring: the SYMPRO-Lung trial.
Billingy NE, Tromp VNMF, Aaronson NK, Hoek RJA, Bogaard HJ, Onwuteaka-Philipsen BD, van de Poll-Franse L, Hugtenburg JG, Belderbos J, Becker-Commissaris A, van den Hurk CJG, Walraven I; SYMPRO-Lung Consortium. Billingy NE, et al. Among authors: van den hurk cjg. J Natl Cancer Inst. 2023 Dec 6;115(12):1515-1525. doi: 10.1093/jnci/djad159. J Natl Cancer Inst. 2023. PMID: 37603720 Free PMC article. Clinical Trial.
The PRO-RCC study: a long-term PROspective Renal Cell Carcinoma cohort in the Netherlands, providing an infrastructure for 'Trial within Cohorts' study designs.
Yildirim H, Widdershoven CV, Aarts MJ, Bex A, Bloemendal HJ, Bochove-Overgaauw DM, Hamberg P, Herbschleb KH, van der Hulle T, Lagerveld BW, van Oijen MG, Oosting SF, van Thienen JV, van der Veldt AA, Westgeest HM, Zeijdner EE, Aben KK, van den Hurk C, Zondervan PJ, Bins AD. Yildirim H, et al. BMC Cancer. 2023 Jul 11;23(1):648. doi: 10.1186/s12885-023-11094-9. BMC Cancer. 2023. PMID: 37434119 Free PMC article.
The impact of the COVID-19 pandemic on renal cancer care.
Yildirim H, Bins AD, van den Hurk C, van Moorselaar RJA, van Oijen MGH, Bex A, Zondervan PJ, Aben KKH. Yildirim H, et al. World J Urol. 2024 Apr 13;42(1):231. doi: 10.1007/s00345-024-04925-2. World J Urol. 2024. PMID: 38613582 Free PMC article.
58 results